Table 1.
Contents of included studies
| Author | Location | Immunosuppression | Number of patients | Contents |
| Meyer et al[9] | France | Cyclosporine, methylpred- nisolone and azathioprine | 162 | HLA-A, B and DR (5-yr graft survival); HLA-DR (1- and 5-yr graft survival) |
| Jakab et al[10] | American | NS | 631 | HLA-A, B and DR (1- and 5-yr graft survival); HLA-A and HLA-B (5-yr graft survival) |
| Neumanna et al[8] | Germany | Cyclosporine, azathioprine and prednisolone | 836 | HLA-A, B and DR (1- and 5-yr graft survival and rejection); HLA-A and HLA-DR (1- and 5-yr graft survival); HLA-B (1-yr graft survival) |
| Hashimoto et al[11] | Japan | Cyclosporine, methylpred- nisolone and azathioprine | 50 | HLA-A, B and DR (1- and 5-yr graft survival) |
| Langrehr et al[12] | Germany | Cyclosporine, azathioprine and prednisolone | 165 | HLA-A, B and DR (1- and 5-yr graft survival and rejection) |
| Suehiro et al[13] | Japan | Tacrolimus and Steroids | 104 | HLA-A, B and DR (1- and 5-yr graft survival and rejection) |
| Harihara et al[14] | Japan | Tacrolimus and Steroids | 85 | HLA-A, B and DR (rejection) |
| Balan et al[7] | American | Cyclosporine, prednisone, and azathioprine or tacrolimus | 799 | HLA-A, B and DR (1- and 5-yr graft survival); HLA-A (5-yr graft survival) |
| Sugawara et al[16] | Japan | Tacrolimus and methyl- prednisolone | 113 | HLA-DR (1-yr graft survival) |
| Doran et al[22] | Germany | NS | 446 | HLA-A, B and DR (1- yr graft survival); HLA-A and HLA-B (1-yr graft survival) |
| Poli et al[15] | Italy | Cyclosporine, azathioprine and tacrolimus | 814 | HLA-DR (5-yr graft survival) |
| Yagihashi et al[18] | American | Cyclosporine, azathioprine and tacrolimus | 347 | HLA-A, HLA-B and HLA-DR (1-yr graft survival) |
| Nikaein et al[21] | American | Cyclosporine and prednisone | 701 | HLA-A, B and DR (1-yr graft survival); HLA-A (1- and 5-yr graft survival); HLA-B and HLA-DR (1-yr graft survival) |
| Markus et al[20] | American | NS | 527 | HLA-A (5-yr graft survival); HLA-DR (1-yr graft survival) |
| Donaldson et al[19] | Britain | Cyclosporine, azathioprine | 466 | HLA-A, B and DR (1-yr graft survival and rejection); HLA-A and HLA-B (1-yr graft survival) |
| Knechtle et al[17] | American | NS | 324 | HLA-A, B and DR (1-yr graft survival); HLA-A, HLA-B and HLA-DR (1-yr graft survival) |
NS: Not specified; HLA: Human leukocyte antigen.